CCC
UL icon

Crescent Capital Consulting’s Unilever UL Stock Holding History

Crescent Capital Consulting’s Portfolio UL Stock Details UL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$121K Buy
1,973
+17
+0.9% +$1.01K 0.02% 213
2021
Q3 		$120K Hold
1,956
– – 0.02% 216
2021
Q2 		$130K Hold
1,956
– – 0.02% 208
2021
Q1 		$123K Hold
1,956
– – 0.03% 215
2020
Q4 		$132K Buy
+1,956
New +$133K 0.03% 188

Other funds holding UL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Crescent Capital Consulting's UL Position: Q4 2021 in Review

Crescent Capital Consulting increased its Unilever (UL) stake by 0.87% in Q4 2021, buying an estimated $1.01K and bringing the position to 1,973 shares worth $121K. The position accounts for 0.02% of the portfolio, ranked #213.

Crescent Capital Consulting first reported a position in UL in Q4 2020 and has held it in 5 quarters since. The position peaked at $132K in Q4 2020. 1,097 funds tracked by Wall St. Rank hold UL as of Q4 2021.

  • Crescent Capital Consulting held 1,973 shares of Unilever worth $121K as of Q4 2021.
  • Crescent Capital Consulting bought 17 Unilever shares in Q4 2021, an estimated $1.01K.
  • Unilever made up 0.02% of Crescent Capital Consulting's portfolio in Q4 2021, its #213 holding.
  • Crescent Capital Consulting first reported a position in Unilever in Q4 2020 and has held it in 5 quarters since.
  • Crescent Capital Consulting's Unilever position peaked at $132K in Q4 2020.
  • 1,097 funds tracked by Wall St. Rank held Unilever as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.